Medicx Fund Regulatory News (MXF)

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Extraordinary General Meeting Results

The Board of MedicX Fund Limited is pleased to announce that at the Extraordinary General Meeting of its Shareholders held at 2.30pm. on 4 March 2010, the following resolution was duly passed as a special resolution without amendment by the required majority:

1. That the directors of the Company from time to time (the "Board") be and are generally authorised to allot up to 85,000,000 Ordinary Shares (within the meaning given in the Company's Articles of Incorporation (the "Articles")) for cash, and in accordance with Article 13.5, the provisions contained in Article 13.3 of the Articles (rights of pre-emption) shall not apply to any such allotment, provided that:

(a) this authorisation shall (unless previously revoked, varied or renewed by the Company) expire on the conclusion of the Company's next annual general meeting, to be held in 2011, save that the Company may make prior to such expiry an offer or agreement which would or might require shares to be allotted after expiry of such period and the Board may allot shares pursuant to such an offer or agreement notwithstanding the expiry of the authority given by this resolution; and

(b) this power shall be limited to the allotment of ordinary shares in the Company's capital in connection with Placing, Open Offer and Offer for Subscription (as such terms are defined in the prospectus issued by the Company dated 15 February 2010, a copy of which is produced to the meeting and initialled by the Chairman to the purposes of identification).

The proxy votes received in respect of the resolution were as follows:

Notes:

·; The votes "for" the resolution are calculated as the aggregate of proxy instructions voting "for" the resolution and the votes at the Chairman's discretion.

·; A vote "withheld" is not a vote in law and is not calculated in the proportion of the votes "for" and "against" the resolution.

·; The total number of voting rights at the proxy deadline was 105,021,215.

End

For further information please contact:

MedicX Fund +44 (0) 1481 723 450

David Staples, Chairman

MedicX Group +44 (0) 808 2025461

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Buchanan Communications +44 (0) 20 7466 5000

Charles Ryland/Lisa Baderoon/Miranda Higham

Information on MedicX Fund Limited

MedicX Fund Limited is a specialist primary care Infrastructure Investor in modern, purpose built healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 51 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK.

The Company's website address is www.medicxfund.com